Nanomedicine News

RSS

Gold Nanoparticles and Targeted Laser Therapy used to Treat Labradoodle with Nasal Adenocarcinoma

When Michael and Sandra Friedlander first came to the Virginia-Maryland College of Veterinary Medicine three years ago with their dog, Grayton, they learned some bad news: Grayton had nasal adenocarcinoma, a form of cancer with a short life expectancy.

6 Aug 2014

NanoViricides Announces Restart of Drug Development Program to Combat Ebola

NanoViricides, Inc. (the “Company”) reports that it is restarting its drug development program to combat Ebola virus infections.

From NanoViricides, Inc 5 Aug 2014

Researchers Employ Radioactive Labelling to Track Key Materials in Nanomedicines

The University of Liverpool has been awarded £2 million to become a leading centre in the UK for tracking the fate in the body of materials used in breakthrough medicines.

5 Aug 2014

Biodegradable, Nanoscale Thin Films Release Drugs in Steady Doses Over a Long Period of Time

About one in four older adults suffers from chronic pain. Many of those people take medication, usually as pills. But this is not an ideal way of treating pain: Patients must take medicine frequently, and can suffer side effects, since the contents of pills spread through the bloodstream to the whole body.

From Massachusetts Institute of Technology 5 Aug 2014

Kala Initiates Nanotechnology-Based LE-MPP Phase 2 Clinical Trial

Kala Pharmaceuticals, Inc., a leading developer of innovative nanotechnology-based ophthalmic products leveraging the company’s proprietary Mucus Penetrating Particle (MPP) platform, today announced the initiation of a Phase 2 clinical trial (KPI-121-C-004) to evaluate KP-121, the company’s loteprednol etabonate MPP (“LE-MPP”) drug product, in patients with intraretinal or subretinal fluid secondary to retinal vein occlusion (RVO) or diabetic macular edema (DME).

1 Aug 2014

IBN Develops Gold Nanoprobe Technology for Unlocking Genetic Profiles

A fast and cost-effective genetic test to determine the correct dosage of blood thinning drugs for the treatment of stroke, heart problems and deep vein thrombosis has been developed by researchers at the Institute of Bioengineering and Nanotechnology (IBN). Using gold nanoprobes, this new technology offers personalized healthcare based on the genetic profile of the patients.

1 Aug 2014

Genomic Medicine Innovator to Serve as Director for Providence Cancer Services and Bioinformatics

Today, Providence Health & Services announced that Dr. Patrick Soon-Shiong, a physician, surgeon and scientist known globally for applying collaborative science and technology to improve the health of patients battling life-threatening disease, will serve as the health care system's new global director for cancer services and bioinformatics.

1 Aug 2014

Peptide Nanofiber Scaffold Holds Hope for Intracerebral Hemorrhage Treatment

Intracerebral hemorrhage is a type of stroke that affects two million people worldwide each year. Despite its seriousness, no effective treatment has yet been developed. But if a recent study in the journal Nanomedicine is right, good news for doctors and patients might one day arrive in a very small package: namely, a “peptide nanofiber scaffold.”

31 Jul 2014

Nanopropellers for Microscopic Medicine

If you thought that the most impressive news in shrinking technology these days was smart watches, think again. Scientists are quietly toiling in their laboratories to create robots that are only nanometers – billionths of a meter – in length, small enough to maneuver inside the human body and possibly inside human cells.

30 Jul 2014

Imbed Bio Awarded NIH SBIR Phase II Grant to Develop Polymeric Nanofilm Dressings with Silver Nanoparticles

Imbed Biosciences, Inc, a medical device company developing advanced materials for wound healing and surgical applications, announced today that it has been awarded a $1.5M competitive Small Business Innovation Research (SBIR) Phase II grant from National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a division of National Institutes of Health (NIH).

30 Jul 2014

Nanomedicine News

Gold Nanoparticles and Targeted Laser Therapy used to Treat Labradoodle with Nasal Adenocarcinoma

NanoViricides Announces Restart of Drug Development Program to Combat Ebola

Researchers Employ Radioactive Labelling to Track Key Materials in Nanomedicines

Biodegradable, Nanoscale Thin Films Release Drugs in Steady Doses Over a Long Period of Time

Kala Initiates Nanotechnology-Based LE-MPP Phase 2 Clinical Trial

IBN Develops Gold Nanoprobe Technology for Unlocking Genetic Profiles

Genomic Medicine Innovator to Serve as Director for Providence Cancer Services and Bioinformatics

Peptide Nanofiber Scaffold Holds Hope for Intracerebral Hemorrhage Treatment

Nanopropellers for Microscopic Medicine

Imbed Bio Awarded NIH SBIR Phase II Grant to Develop Polymeric Nanofilm Dressings with Silver Nanoparticles

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials